OpenCitationsmetadata only
Phase I Study Of Single-Agent CC-292, A Highly Selective Brutons Tyrosine Kinase Inhibitor, In Relapsed/Refractory Chronic Lymphocytic Leukemia
citations, doi, seed:10.1186/1756-8722-6
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 19621
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.